GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » EV-to-EBIT

Albert Labs International (XCNQ:ABRT) EV-to-EBIT : 1.24 (As of May. 27, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Albert Labs International's Enterprise Value is C$0.75 Mil. Albert Labs International's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.61 Mil. Therefore, Albert Labs International's EV-to-EBIT for today is 1.24.

The historical rank and industry rank for Albert Labs International's EV-to-EBIT or its related term are showing as below:

XCNQ:ABRT' s EV-to-EBIT Range Over the Past 10 Years
Min: -7.87   Med: 0   Max: 2.46
Current: 1.24

During the past 2 years, the highest EV-to-EBIT of Albert Labs International was 2.46. The lowest was -7.87. And the median was 0.00.

XCNQ:ABRT's EV-to-EBIT is ranked better than
65.09% of 424 companies
in the Biotechnology industry
Industry Median: 10 vs XCNQ:ABRT: 1.24

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Albert Labs International's Enterprise Value for the quarter that ended in Sep. 2023 was C$1.50 Mil. Albert Labs International's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.61 Mil. Albert Labs International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 40.71%.


Albert Labs International EV-to-EBIT Historical Data

The historical data trend for Albert Labs International's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International EV-to-EBIT Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
EV-to-EBIT
- -0.64

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.72 -0.64 -4.45 44.98 2.46

Competitive Comparison of Albert Labs International's EV-to-EBIT

For the Biotechnology subindustry, Albert Labs International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert Labs International's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Albert Labs International's EV-to-EBIT falls into.



Albert Labs International EV-to-EBIT Calculation

Albert Labs International's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.754/0.61
=1.24

Albert Labs International's current Enterprise Value is C$0.75 Mil.
Albert Labs International's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert Labs International  (XCNQ:ABRT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Albert Labs International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=0.61/1.498266
=40.71 %

Albert Labs International's Enterprise Value for the quarter that ended in Sep. 2023 was C$1.50 Mil.
Albert Labs International's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert Labs International EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Albert Labs International's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines